SynthesisBMC medical education2026
The impact of integrating generative artificial intelligence into medical education on short-term learning outcomes: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in BMC medical education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pedagogical Efficacy of LLM-Generated Synthetic Data Versus Real-World Clinical Records: A Randomized Controlled Non-Inferiority Trial.Perspectives on medical education · 2026Trial
- AI-Empowered Nuclear Medicine Education, Part 1: Theoretical and Ethical Foundation.Journal of nuclear medicine technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundGenerative artificial intelligence (GenAI) technologies —exemplified by large language models (LLMs) such as ChatGPT and DeepSeek—have attracted substantial interest in medical education for their capacity to generate content, adapt to individual learners, and support interactive dialogue. Whether these technologies produce measurable improvements in educational outcomes remains uncertain, and this evidence gap has constrained broader adoption. We conducted this systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the effects of GenAI-assisted teaching on knowledge acquisition, clinical skills, and learner attitudes.
methodsWe conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) following the PRISMA 2020 guidelines. The study protocol was registered on PROSPERO (CRD420261277187).Six databases (PubMed, Cochrane Library, Embase, Web of Science, CNKI, and Wanfang) were searched from January 2020 to February 2026. We included RCTs in which GenAI-integrated medical education was compared against traditional teaching or non-GenAI digital teaching, with participants being medical students, interns, or residents. Risk of bias was evaluated with the Cochrane RoB 2 tool; the GRADE framework was used to judge evidence certainty. Pooling was done through random-effects models with REML estimation.
resultsWe identified 20 eligible RCTs (1413 participants in total). Post-intervention knowledge scores were higher in GenAI groups (SMD = 0.99, 95% CI: 0.49–1.49, P = 0.001; k = 11; I2 = 86.7%; GRADE: low certainty), and so were clinical skill scores (SMD = 1.09, 95% CI: 0.81–1.38, P < 0.001; k = 8; I2 = 41.0%; GRADE: moderate certainty). At follow-up, knowledge retention remained significant (SMD = 0.51, 95% CI: 0.24–0.78, P = 0.010; k = 4; I2 = 0%; GRADE: moderate certainty). Publication bias was not detected by Egger’s test (P = 0.104); trim-and-fill adjustment gave a similar pooled estimate (SMD = 0.90). Subgroup comparisons by AI tool type, learner level, interaction modality, and risk of bias were all non-significant.
conclusionGenAI-assisted teaching was associated with moderate-to-large pooled standardised mean differences for clinical skills (SMD = 1.09; moderate certainty) and post-intervention knowledge (SMD = 0.99; low certainty). However, the prediction interval for knowledge crossed zero (− 0.57 to 2.56), indicating that the direction of benefit cannot be assumed in future contexts. In four studies, knowledge gains were observed at follow-up (SMD = 0.51; moderate certainty), though the small number of studies limits confidence in durability. Evidence certainty is low to moderate, owing to high heterogeneity, risk of bias, and the absence of blinding. Current evidence is insufficient to draw definitive conclusions; GenAI may serve as a useful supplement to conventional instruction but should not be adopted as a replacement without evidence from well-powered, pre-registered, multi-centre trials.
trial registrationPROSPERO registration: CRD420261277187.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.